Liver CancerSCIE

文章摘录

• First-line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis Author: Fong, Khi Yung; Zhao, Joseph Jonathan; Sultana, Rehena; Lee, Joycelyn Jie Xin; Lee, Suat Ying; Chan, Stephen Lam; Yau, Thomas; Tai, David Wai Meng; Sundar, Raghav; Too, Chow Wei Journal: LIVER CANCER. 2023; Vol. 12, Issue 1, pp. 7-18. DOI: 10.1159/000526639
• Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated With Atezolizumab Plus Bevacizumab Author: Hsu, Chiun; Ducreux, Michel; Zhu, Andrew X.; Qin, Shukui; Ikeda, Masafumi; Kim, Tae-You; Galle, Peter R.; Finn, Richard S.; Chen, Ethan; Ma, Ning; Hu, Youyou; Li, Lindong; Cheng, Ann-Lii Journal: LIVER CANCER. 2023; Vol. 12, Issue 1, pp. 44-56. DOI: 10.1159/000525499
• Dietary fat composition affects hepatic angiogenesis and lymphangiogenesis in HCV core gene transgenic mice Author: Diao, Pan; Wang, Yaping; Jia, Fangping; Wang, Xiaojing; Hu, Xiao; Kimura, Takefumi; Sato, Yoshiko; Moriya, Kyoji; Koike, Kazuhiko; Nakayama, Jun; Tanaka, Naoki Journal: LIVER CANCER. 2023; Vol. 12, Issue 1, pp. 57-71. DOI: 10.1159/000525546
• Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial Author: Ren, Zhenggang; Ducreux, Michel; Abou-Alfa, Ghassan K.; Merle, Philippe; Fang, Weijia; Edeline, Julien; Li, Zhiwei; Wu, Lihua; Assenat, Eric; Hu, Sheng; Rimassa, Lorenza; Zhang, Tao; Blanc, Jean-Frederic; Pan, Hongming; Ross, Paul; Yen, Chia-Jui; Tran, Albert; Shao, Guoliang; Bouattour, Mohamed; Chen, Yajin; Meyer, Tim; Hou, Jinlin; Tougeron, David; Bai, Yuxian; Hou, Ming-Mo; Meng, Zhiqiang; Wu, John; Li, Vincent; Chica-Duque, Sandra; Cheng, Ann-Lii Journal: LIVER CANCER. 2023; Vol. 12, Issue 1, pp. 72-84. DOI: 10.1159/000527175
• Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management Author: Ye, Liangtao; Schneider, Julia S. S.; Ben Khaled, Najib; Schirmacher, Peter; Seifert, Carolin; Frey, Lea; He, Yulong; Geier, Andreas; De Toni, Enrico N. N.; Zhang, Changhua; Reiter, Florian P. P. Journal: LIVER CANCER. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000530700
• Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review Author: Vogel, Arndt; Kelley, Robin Katie; Johnson, Philip; Merle, Philippe; Yau, Thomas; Kudo, Masatoshi; Meyer, Tim; Rimassa, Lorenza Journal: LIVER CANCER. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000529173
• Achievement of Complete Response and Drug-free Status by Atezolizumab Plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-stage Hepatocellular Carcinoma: A Multicenter Proof-of-Concept Study Author: Kudo, Masatoshi; Aoki, Tomoko; Ueshima, Kazuomi; Tsuchiya, Kaoru; Morita, Masahiro; Chishina, Hirokazu; Takita, Masahiro; Hagiwara, Satoru; Minami, Yasunori; Ida, Hiroshi; Nishida, Naoshi; Ogawa, Chikara; Tomonari, Tetsu; Nakamura, Noriaki; Kuroda, Hidekatsu; Takebe, Atsushi; Takeyama, Yoshifumi; Hidaka, Masaaki; Eguchi, Susumu; Chan, Stephen L.; Kurosaki, Masayuki; Izumi, Namiki Journal: LIVER CANCER. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000529574
• Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer-Term Follow-Up From the Phase 3 KEYNOTE-240 Trial Author: Merle, Philippe; Kudo, Masatoshi; Edeline, Julien; Bouattour, Mohamed; Cheng, Ann-Lii; Chan, Stephen Lam; Yau, Thomas; Garrido, Marcelo; Knox, Jennifer; Daniele, Bruno; Breder, Valeriy; Lim, Ho Yeong; Ogasawara, Sadahisa; Cattan, Stephane; Chao, Yee; Siegel, Abby B.; Martinez-Forero, Ivan; Wei, Ziwen; Liu, Chih-Chin; Finn, Richard S. Journal: LIVER CANCER. 2023; Vol. , Issue , pp. -. DOI: 10.1159/000529636